Using patents to ensure access to pioneering cell technology
"Disease affects us all. It shows no prejudice. CiRA therefore believes that all iPS cell technology should be available to all people, regardless of nationality. For this reason, we are working to obtain patents in as many countries as possible.
In this endeavor, we give much credit to the World Intellectual Property Organization’s Patent Cooperation Treaty (PCT). As of May 2015, Kyoto University holds patents relating to iPS cell technologies in 30 different countries. Like other universities and research institutes with limited financial and human resources, Kyoto University has taken advantage of the PCT’s simplified and cost-effective procedures. Using the PCT also gives us more time to assess whether we really need to patent a given technology."
By Professor Shinya Yamanaka, M.D., Ph.D., Director of the Center for iPS Cell Research and Application, Kyoto University, Japan (Read the full article )Archives
US and China Drive International Patent Filing Growth in Record-Setting Year